Drafeb 80mg Tablet

Drafeb 80mg Tablet is prescribed for treating gout, a common yet painful form of inflammatory arthritis. Gout results from the excess buildup of uric acids, causing the joints to swell and stiffen. This medication contains febuxostat, a xanthine oxidase inhibitor that lowers the amount of uric acid produced in the body. Febuxostat is also used in the prevention of severe gout flares.

Drafeb 80mg Tablet can be taken before or after food. It is crucial to adhere to your doctor's prescription even in the absence of a gout flare-up. Discontinuing the medication may exacerbate symptoms by promoting further urate crystal deposition in the joints. Try not to chew or break the tablet; swallow it whole. To prevent adverse effects, precisely follow the dosage instructions given by your doctor.

The common side effects of Drafeb 80mg Tablet include nausea, joint pain, headache, mild rash and diarrhoea. These adverse effects usually go away on their own and should not be of concern. If they persist or become worse, contact your doctor.

Drafeb 80mg Tablet may be contraindicated (unsafe) for people who have/had heart disease, ischemic stroke, thyroid diseases, heart attack, renal impairment, liver diseases, hyperuricemia, Lesch-Nyhan syndrome and hypersensitivity to febuxostat. Always let your doctor know of any health conditions you might have. Generally, this medicine is considered safe for most people.

Drafeb 80mg Tablet, containing febuxostat, is a prescription medication that treats the symptoms of chronic gout. It is also used in the prevention of severe gout flares. Febuxostat is often prescribed for the treatment of gout in patients who have failed to achieve successful results with, or are intolerant to, allopurinol - another more commonly used medicine that treats gout.

Gout, a form of arthritis, is characterised by uric acid buildup in the bloodstream, leading to joint inflammation. The acute form of gout presents as excruciating pain in a single joint, while chronic gout causes recurring episodes of pain and inflammation that may affect multiple joints. Such symptoms require prompt treatment with medicines like febuxostat or allopurinol to prevent long-term joint damage and disability.

Drafeb 80mg Tablet treats gout by lowering the amount of uric acid produced in the body. Gout is a painful form of inflammatory arthritis that results from the excess buildup of uric acids in the joints. This medicine reduces the uric acid levels in the blood, promoting the breakdown of the uric acid crystals in the joint that causes pain and inflammation.

Drafeb 80mg Tablet contains febuxostat, which is a xanthine oxidase inhibitor. It works by inhibiting an enzyme called the xanthine oxidase enzyme, which consequently hinders the conversion of a purine-based organic compound called hypoxanthine to xanthine and eventually to uric acid. The inhibition of xanthine oxidase effectively lowers the uric acid levels in the body. This process, however, does not interfere with the enzymes responsible for purine and pyrimidine synthesis.

• Febuxostat (medlineplus.gov)
• Febuxostat (ncbi.nlm.nih.gov)
• ULORIC (febuxostat) tablet for oral use (accessdata.fda.gov)
• Long-Term Safety of Febuxostat in Subjects With Gout (clinicaltrials.gov)